Thermo- and pH-responsive, Lipid-coated, Mesoporous Silica Nanoparticle-based Dual Drug Delivery System To Improve the Antitumor Effect of Hydrophobic Drugs.
暂无分享,去创建一个
Yi Feng | Min Wu | Ning Li | Qian Yang | Tian-yu Chen | Huanli Yin
[1] S. M. Taghdisi,et al. Encapsulation of Thermo‐responsive Gel in pH‐sensitive Polymersomes as Dual‐Responsive Smart carriers for Controlled Release of Doxorubicin , 2018, Journal of controlled release : official journal of the Controlled Release Society.
[2] Ramasamy Bhanumathi,et al. Drug-Carrying Capacity and Anticancer Effect of the Folic Acid- and Berberine-Loaded Silver Nanomaterial To Regulate the AKT-ERK Pathway in Breast Cancer , 2018, ACS omega.
[3] Q. Lu,et al. Biodegradable Cyclomatrix Polyphosphazene Nanoparticles: A Novel pH-Responsive Drug Self-Framed Delivery System. , 2018, ACS applied materials & interfaces.
[4] Kun Shi,et al. Targeting Delivery of Lidocaine and Cisplatin by Nanogel Enhances Chemotherapy and Alleviates Metastasis. , 2018, ACS applied materials & interfaces.
[5] Z. Qian,et al. Targeting Delivery of Rapamycin with Anti-Collagen IV Peptide Conjugated Fe₃O₄@Nanogels System for Vascular Restenosis Therapy. , 2018, Journal of biomedical nanotechnology.
[6] Z. Wang,et al. Bioinspired Diselenide‐Bridged Mesoporous Silica Nanoparticles for Dual‐Responsive Protein Delivery , 2018, Advanced materials.
[7] Jeong Eon Lee,et al. Berberine Suppresses Fibronectin Expression through Inhibition of c-Jun Phosphorylation in Breast Cancer Cells , 2018, Journal of breast cancer.
[8] Min Zhu,et al. Magnetic mesoporous silica nanoparticles coated with thermo-responsive copolymer for potential chemo- and magnetic hyperthermia therapy , 2018 .
[9] Tao Shen,et al. Combination of berberine and evodiamine inhibits intestinal cholesterol absorption in high fat diet induced hyperlipidemic rats , 2017, Lipids in Health and Disease.
[10] Jia Guo,et al. Targeted Soft Biodegradable Glycine/PEG/RGD-Modified Poly(methacrylic acid) Nanobubbles as Intelligent Theranostic Vehicles for Drug Delivery. , 2017, ACS applied materials & interfaces.
[11] Cheng-wei Gu,et al. Berberine displays antitumor activity in esophageal cancer cells in vitro , 2017, World journal of gastroenterology.
[12] Jing Li,et al. Berberine‐loaded Janus nanocarriers for magnetic field‐enhanced therapy against hepatocellular carcinoma , 2017, Chemical biology & drug design.
[13] G. Pastorin,et al. Liposome encapsulated berberine treatment attenuates cardiac dysfunction after myocardial infarction , 2017, Journal of controlled release : official journal of the Controlled Release Society.
[14] Yufang Zhu,et al. Aldehyde-functionalized dendritic mesoporous silica nanoparticles as potential nanocarriers for pH-responsive protein drug delivery. , 2017, Materials science & engineering. C, Materials for biological applications.
[15] Yufang Zhu,et al. Mesoporous Silica Nanoparticles Capped with Graphene Quantum Dots for Potential Chemo-Photothermal Synergistic Cancer Therapy. , 2017, Langmuir : the ACS journal of surfaces and colloids.
[16] Yufang Zhu,et al. Graphene Quantum Dots-Capped Magnetic Mesoporous Silica Nanoparticles as a Multifunctional Platform for Controlled Drug Delivery, Magnetic Hyperthermia, and Photothermal Therapy. , 2017, Small.
[17] Shuo Yang,et al. Berberine inhibits EGFR signaling and enhances the antitumor effects of EGFR inhibitors in gastric cancer , 2016, Oncotarget.
[18] R. Agarwal,et al. A novel alkaloid, evodiamine causes nuclear localization of cytochrome-c and induces apoptosis independent of p53 in human lung cancer cells. , 2016, Biochemical and biophysical research communications.
[19] E. Harth,et al. Dual drug delivery of tamoxifen and quercetin: Regulated metabolism for anticancer treatment with nanosponges. , 2015, Journal of controlled release : official journal of the Controlled Release Society.
[20] M. Yuen,et al. Berberine and Coptidis Rhizoma as potential anticancer agents: Recent updates and future perspectives. , 2015, Journal of ethnopharmacology.
[21] W. Ni,et al. Berberine as a promising anti-diabetic nephropathy drug: An analysis of its effects and mechanisms. , 2015, European journal of pharmacology.
[22] X. Wang,et al. Magnetic, fluorescent, and thermo-responsive poly(MMA-NIPAM-Tb(AA)3Phen)/Fe3O4 multifunctional nanospheres prepared by emulsifier-free emulsion polymerization , 2015, Journal of biomaterials applications.
[23] Yufang Zhu,et al. DNA-capped Fe3O4/SiO2 magnetic mesoporous silica nanoparticles for potential controlled drug release and hyperthermia , 2015 .
[24] Sang Hoon Joo,et al. Noncovalent Polymer‐Gatekeeper in Mesoporous Silica Nanoparticles as a Targeted Drug Delivery Platform , 2015 .
[25] Wei Liu,et al. A Network Pharmacology Study of Chinese Medicine QiShenYiQi to Reveal Its Underlying Multi-Compound, Multi-Target, Multi-Pathway Mode of Action , 2014, PloS one.
[26] Xiaoling Zhang,et al. The multi-target capabilities of the compounds in a TCM used to treat sepsis and their in silico pharmacology. , 2013, Complementary therapies in medicine.
[27] Vladimir P Torchilin,et al. pH-sensitive poly(histidine)-PEG/DSPE-PEG co-polymer micelles for cytosolic drug delivery. , 2013, Biomaterials.
[28] J. Hartley,et al. Evodiamine, a dual catalytic inhibitor of type I and II topoisomerases, exhibits enhanced inhibition against camptothecin resistant cells. , 2012, Phytomedicine : international journal of phytotherapy and phytopharmacology.
[29] S. Kao,et al. Inhibitory effects of Zuo-Jin-Wan and its alkaloidal ingredients on activator protein 1, nuclear factor-κB, and cellular transformation in HepG2 cells. , 2011, Fitoterapia.
[30] Jun-Lin Jiang,et al. Evodiamine: A Novel Anti-Cancer Alkaloid from Evodia rutaecarpa , 2009, Molecules.
[31] Y. Qi,et al. Enhancement of apoptosis of human hepatocellular carcinoma SMMC-7721 cells through synergy of berberine and evodiamine. , 2008, Phytomedicine : international journal of phytotherapy and phytopharmacology.